432 related articles for article (PubMed ID: 33961923)
1. Kidney Transplantation in Monoclonal Immunoglobulin Deposition Disease: A Report of 6 Cases.
Molina-Andújar A; Tovar N; Cuadrado E; Castrejón de Anta N; Revuelta I; Cucchiari D; Cofan F; Esforzado N; Cibeira MT; Rosiñol L; Bladé J; Diekmann F; Fernández de Larrea C; Quintana LF
Am J Kidney Dis; 2021 Nov; 78(5):755-759. PubMed ID: 33961923
[TBL] [Abstract][Full Text] [Related]
2. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.
Batalini F; Econimo L; Quillen K; Sloan JM; Sarosiek S; Brauneis D; Havasi A; Stern L; Dember LM; Sanchorawala V
Biol Blood Marrow Transplant; 2018 Jan; 24(1):127-132. PubMed ID: 28865972
[TBL] [Abstract][Full Text] [Related]
3. High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease.
Hassoun H; Flombaum C; D'Agati VD; Rafferty BT; Cohen A; Klimek VM; Boruchov A; Kewalramani T; Reich L; Nimer SD; Comenzo RL
Bone Marrow Transplant; 2008 Sep; 42(6):405-12. PubMed ID: 18574442
[TBL] [Abstract][Full Text] [Related]
4. Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis.
Gupta VK; Brauneis D; Shelton AC; Quillen K; Sarosiek S; Sloan JM; Sanchorawala V
Biol Blood Marrow Transplant; 2019 May; 25(5):e169-e173. PubMed ID: 30639823
[TBL] [Abstract][Full Text] [Related]
5. The Role of Kidney Transplantation in Monoclonal Ig Deposition Disease.
Angel-Korman A; Stern L; Angel Y; Sarosiek S; Menn-Josephy H; Francis J; Ghai S; Sloan JM; Sanchorawala V; Havasi A
Kidney Int Rep; 2020 Apr; 5(4):485-493. PubMed ID: 32274452
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
7. Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
Pianko MJ; Tiutan T; Derkach A; Flynn J; Salvatore SP; Jaffer-Sathick I; Rossi AC; Lahoud O; Hultcrantz M; Shah UA; Maclachlan K; Chung DJ; Shah GL; Landau HJ; Korde N; Mailankody S; Lesokhin AM; Tan C; Scordo M; Jaimes EA; Giralt SA; Usmani S; Hassoun H
Am J Hematol; 2023 Mar; 98(3):421-431. PubMed ID: 36588413
[TBL] [Abstract][Full Text] [Related]
8. Treatment of multiple myeloma.
San Miguel JF; Bladé Creixenti J; García-Sanz R
Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
[TBL] [Abstract][Full Text] [Related]
9. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
[TBL] [Abstract][Full Text] [Related]
10. Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report.
Al-Zoairy R; Viveiros A; Zoller H; Schneeberger S; Oberhuber G; Gunsilius E; Tilg H; Wolf D; Rudzki JD
J Med Case Rep; 2020 Oct; 14(1):201. PubMed ID: 33099313
[TBL] [Abstract][Full Text] [Related]
11. Kidney Transplantation for Kidney Failure Due to Multiple Myeloma: Case Reports.
Le TX; Wolf JL; Peralta CA; Webber AB
Am J Kidney Dis; 2017 Jun; 69(6):858-862. PubMed ID: 28320553
[TBL] [Abstract][Full Text] [Related]
12. Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.
Ziogas DC; Kastritis E; Terpos E; Roussou M; Migkou M; Gavriatopoulou M; Spanomichou D; Eleutherakis-Papaiakovou E; Fotiou D; Panagiotidis I; Kafantari E; Psimenou E; Boletis I; Vlahakos DV; Gakiopoulou H; Matsouka C; Dimopoulos MA
Leuk Lymphoma; 2017 Aug; 58(8):1832-1839. PubMed ID: 27967286
[TBL] [Abstract][Full Text] [Related]
13. Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.
Tosi P; Zamagni E; Ronconi S; Benni M; Motta MR; Rizzi S; Tura S; Cavo M
Leukemia; 2000 Jul; 14(7):1310-3. PubMed ID: 10914557
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.
Kaposztas Z; Kahan BD; Katz SM; Van Buren CT; Cherem L
Transplant Proc; 2009 Dec; 41(10):4407-10. PubMed ID: 20005409
[TBL] [Abstract][Full Text] [Related]
15. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with renal monoclonal immunoglobulin deposition disease.
Kourelis TV; Nasr SH; Dispenzieri A; Kumar SK; Gertz MA; Fervenza FC; Buadi FK; Lacy MQ; Erickson SB; Cosio FG; Kapoor P; Lust JA; Hayman SR; Rajkumar V; Zeldenrust SR; Russell SJ; Dingli D; Lin Y; Gonsalves W; Lorenz EC; Zand L; Kyle RA; Leung N
Am J Hematol; 2016 Nov; 91(11):1123-1128. PubMed ID: 27501122
[TBL] [Abstract][Full Text] [Related]
17. [Autologous haematopoietic stem cell transplantation in patients with multiple myeloma complicated by dialysis-dependent renal failure].
Firsova MV; Mendeleeva LP; Solovev MV; Rekhtina IG; Pokrovskaya OS; Urnova ES; Soboleva NP; Dvirnyk VN; Klyasova GA; Kuzmina LA; Savchenko VG
Ter Arkh; 2020 Sep; 92(7):70-76. PubMed ID: 33346447
[TBL] [Abstract][Full Text] [Related]
18. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series.
Heybeli C; Alexander MP; Bentall AJ; Amer H; Buadi FK; Dean PG; Dingli D; Dispenzieri A; El Ters M; Gertz MA; Issa NS; Kapoor P; Kourelis T; Kukla A; Kumar S; Lacy MQ; Lorenz EC; Muchtar E; Murray DL; Nasr SH; Prieto M; Rajkumar SV; Schinstock CA; Stegall MD; Warsame R; Leung N
Am J Kidney Dis; 2022 Feb; 79(2):202-216. PubMed ID: 34175375
[TBL] [Abstract][Full Text] [Related]
19. Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.
Fung HC; Cohen S; Rodriguez R; Smith D; Krishnan A; Somlo G; Sahebi F; Senitzer D; O'Donnell MR; Stein A; Snyder DS; Spielberger R; Bhatia R; Falk P; Molina A; Nademanee A; Parker P; Kogut N; Popplewell L; Vora N; Margolin K; Forman SJ
Biol Blood Marrow Transplant; 2003 Oct; 9(10):649-56. PubMed ID: 14569561
[TBL] [Abstract][Full Text] [Related]
20. Induction bortezomib in Al amyloidosis followed by high dose melphalan and autologous stem cell transplantation: a single institution retrospective study.
Scott EC; Heitner SB; Dibb W; Meyers G; Smith SD; Abar F; Kovacsovics T; Perez-Avraham G; Stentz A; Frires R; Dibb J; Maziarz RT
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):424-430.e1. PubMed ID: 24650974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
